AAHP Statement Regarding FDA Action Against Zicam

AAHP Statement Regarding FDA Action Against Zicam Intranasal Zinc Products June 19, 2009–The American Association of Homeopathic Pharmacists (AAHP) acknowledges the U.S. Food and Drug Administration’s (FDA) action to protect the public by sending a Warning Letter to Matrixx Innovations, Inc. in connection with that company’s sale of Zicam intranasal zinc medications. According to FDA,Continue Reading

AAHP Response to AP Article on Zicam

Homeopathic Pharmacists Association Highlights the Extraordinary Safety Record of Homeopathic Medicines June 19, 2009—The American Association of Homeopathic Pharmacists (AAHP) acknowledges the U.S. Food and Drug Administration’s (FDA) action to protect the public by sending a Warning Letter to Matrixx Innovations, Inc. in connection with that company’s sale of Zicam intranasal zinc medications. According toContinue Reading

Homeopathy officially recognized in Belgium

The practice of homeopathy received a legal recognition in Belgium on last month, but at the same time stricter regulations have been imposed on the sector.The federal government gave the green light in July last year, but the Royal Decree was only published in the Staatsblad, the official news letter issued by the Belgian government,Continue Reading

Sept ’14 Member Meeting Successes

The AAHP’s Semi-Annual Member Meeting in Baltimore was an unparalleled success with two new highlights capping the event. After an opening welcome by AAHP President Mark Land, the meeting began with an informative roundtable discussion by Al Lorman, Pete Evich and Jay Borneman. Each provided a quick perspective on current challenges facing the industry. AmongContinue Reading

AAHP Addresses OTC Homeopathic Drug Products for Asthma

The American Association of Homeopathic Pharmacists (AAHP), representing the principal manufacturers and distributors of homeopathic medicines in the United States, said today it fully supports the Food and Drug Administration’s position that consumers should seek the advice of their health care provider if they suspect they or their children are experiencing symptoms of asthma, whichContinue Reading

Speakers at FDA Hearing Praise Success of Homeopathic Regulatory Framework

Silver Spring, Md., April 20, 2015—The American Association of Homeopathic Pharmacists (AAHP) today told the U.S. Food and Drug Administration that the agency’s regulatory policy for homeopathic medicines has worked effectively for the last 25 years to protect the public health and provide consumer access to safe homeopathic medicines. AAHP, the industry’s trade association, wasContinue Reading

Homeopathic Industry Proposes More Broad Use of Disclosures to FTC as the Path Forward

Industry leaders provide perspective on partnership opportunities for Federal Trade Commission Washington, D.C., Sept. 21, 2015— To better help consumers make informed choices, the American Association of Homeopathic Pharmacists (AAHP) proposed strengthening product label and advertising disclosures to the Federal Trade Commission (FTC) today in Washington, D.C. at the agency’s “Homeopathic Medicine & Advertising” workshop.Continue Reading

Experts Discuss Advertising of Homeopathic Medicines at FTC Workshop

Washington, D.C., Sept. 22, 2015—Trade association leaders, experts in consumer marketing and regulations, and top physicians came together on Monday, September 21 in Washington, D.C. at “Homeopathic Medicine & Advertising: A Federal Trade Commission (FTC) Workshop.” President of the American Association of Homeopathic Pharmacists (AAHP) Mark Land stated, “We have a remarkable story to shareContinue Reading

2016 Annual Meeting Recap

March, 2016—Thirty-two members of the American Association of Homeopathic Pharmacists (AAHP) came together to discuss the most pressing industry issues as well as the association’s current programs and initiatives. The annual meeting took place on March 11, 2016 during the Natural Products Expo West in Anaheim, Calif. Attendees learned about the complexities—and potentially significant financialContinue Reading

Annual HPCUS Meeting Recap

In early April, the Homeopathic Pharmacopeia Convention of the United States (HPCUS) held its annual meeting. During the four-day event, multiple committees, the board, and the general membership came together for reports and ongoing action. The highlight of the General Membership meeting was a presentation by Rick Lostritto, Ph.D. of the U.S. FDA’s office ofContinue Reading

Homeopathic Association Works with FDA to Educate Manufacturers

MILWAUKIE, Ore. (July 6, 2016) – The American Association of Homeopathic Pharmacists’ (AAHP) latest educational webinar illustrates the homeopathic industry fostering a relationship with the U.S. Food and Drug Administration (FDA) to ensure the highest quality of safe medicines to retailers, consumers and health practitioners across the U.S. Per the request of AAHP, the agencyContinue Reading

Homeopathic Manufacturers Honor Sen. Barbara Ann Mikulski for Career-Long Support of Complementary Health Care

MILWAUKIE, Ore., Oct. 4, 2016 — Senator Barbara Ann Mikulski (D-Md.) recently received a Legislative Excellence Award from the American Association of Homeopathic Pharmacists (AAHP), the U.S. trade association for the manufacturers of homeopathic medicines. Presented during a special ceremony at the association’s bi-annual conference in Baltimore, Md., the prestigious award recognizes the senator’s supportContinue Reading

AAHP Encourages Clear and Open Communication on Teething Medicines Tragedies

In the interest of public safety, the American Association of Homeopathic Pharmacists (AAHP) encourages the U.S. Food and Drug Administration to provide clear and open communication on their ongoing investigation of the safety of homeopathic teething medicine. Representing the manufacturers, distributors and marketers of homeopathic drugs, AAHP secretary Eric Foxman said industry leaders were surprisedContinue Reading

Upcoming Webinar to Address FDA Inspections of Homeopathic Manufacturing Facilities

MILWAUKIE, Ore. (November 22, 2016) – The American Association of Homeopathic Pharmacists’ (AAHP) newest educational webinar will take place on Thursday, Dec. 1, 2016 at 1:00 p.m. EST and will provide best practices for homeopathic manufacturing facilities, specifically as they relate to U.S. Food and Drug Administration (FDA) inspections. Designed for CEOs and managers responsibleContinue Reading

2016 Year-In-Review

As 2016 comes to a close and we think back on all the many amazing and unexpected things that have happened, we also note the many activities undertaken and accomplishments achieved by the AAHP on behalf of its membership: We held two successful membership meetings that united industry leaders in sharing best practices. We hostedContinue Reading

Manufacturers of Homeopathic Medicines Review FDA Test Results and New Application of Technology

MILWAUKIE, Ore., Feb. 14, 2017 — The U.S. Food and Drug Administration (FDA) announced on Jan. 27 that its laboratory analysis found inconsistent levels of some specific constituents in certain homeopathic teething tablets. While the industry fully supports and shares the agency’s efforts to safeguard public health, the American Association of Homeopathic Pharmacists (AAHP) cautionsContinue Reading